EarningsQ4 2021 Earnings Report

Nektar Therapeutics (NKTR) Q4 2021 Earnings Report

0 Followers

MX:NKTR Q4 2021 EPS Results

Actual EPS-$216.32

Consensus EPS-$219.97

Beat/MissBeat by +$3.65

One Year Ago EPS-$177.98

Actual Revenue$456.53M

Expected Revenue$625.45M

Beat/MissMissed by -$168.93M

YoY Revenue Growth+6.59%

QuarterQ4 2021

Date02/28/2022

TimeAfter Close

Conference CallMonday, February 28, 2022

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.77 / -	-34.136	―
Aug 13, 2026	2026 (Q2)	-35.98 / -22.45	-53.851	58.31% (+31.40)
May 07, 2026	2026 (Q1)	-28.88 / -33.22	-65.716	49.44% (+32.49)
Mar 12, 2026	2025 (Q4)	-45.16 / -32.49	8.215	-495.56% (-40.71)
Nov 06, 2025	2025 (Q3)	-49.01 / -34.14	-49.287	30.74% (+15.15)
Aug 07, 2025	2025 (Q2)	-55.27 / -53.85	-68.454	21.33% (+14.60)
May 08, 2025	2025 (Q1)	-46.80 / -65.72	-52.025	-26.32% (-13.69)
Mar 12, 2025	2024 (Q4)	-37.13 / 8.21	-60.24	113.64% (+68.45)
Nov 07, 2024	2024 (Q3)	-54.49 / -49.29	-65.716	25.00% (+16.43)
Aug 08, 2024	2024 (Q2)	-50.66 / -68.45	-73.931	7.41% (+5.48)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed